1. Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines

   • Masaya Hattori
   • Naoko Honma
   • Yutaka Yamamoto

   Special Article Open access 04 March 2024 Pages: 335 - 339

2. The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment

   • Yutaka Yamamoto
   • Chikako Yamauchi
   • Shigehira Saji

   Special Article Open access 03 April 2024 Pages: 340 - 346

   

3. The Japanese breast cancer society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition

   • Michio Yoshimura
   • Chikako Yamauchi
   • Shigehira Saji

   Special Article Open access 05 April 2024 Pages: 347 - 357

4. The role of the BTLA–HVEM complex in the pathogenesis of breast cancer

   • Xue Hu

   Review Article 14 March 2024 Pages: 358 - 370

   

5. Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models

   • Hongyan Zheng
   • Lihua Wu
   • Ge Lou

   Original Article 30 January 2024 Pages: 371 - 381

   

6. Preliminary report on ultrashort perioperative partial-breast irradiation with multicatheter interstitial brachytherapy for early-stage breast cancer

   • Kazuhiko Sato
   • Hiromi Fuchikami
   • Masahiro Kato

   Original Article 15 February 2024 Pages: 382 - 390

   

7. Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants

   • Nalee Kim
   • Won Kyung Cho
   • Haeyoung Kim

   Original Article 18 February 2024 Pages: 391 - 400

   

8. Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in Japan

   • Yasue Tsuchida
   • Naoki Niikura
   • Naoki Hayashi

   Original Article 07 March 2024 Pages: 401 - 408

   

9. A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer

   • Kumiko Kida
   • Akimitsu Yamada
   • Takashi Ishikawa

   Original Article 08 March 2024 Pages: 409 - 416

   

10. The correlation study between TOP2A gene expression in circulating tumor cells and chemotherapeutic drug resistance of patients with breast cancer

    • Jin-hui Ye
    • Jian Yu
    • Yue-mei Mo

    Original Article Open access 01 April 2024 Pages: 417 - 425

    

11. Enhancing radiosensitivity in triple-negative breast cancer through targeting ELOB

    • Guo Li
    • Xinyue Lin
    • Zhichao Fu

    Original Article 12 March 2024 Pages: 426 - 439

    

12. SIRT1 mediates breast cancer development and tumorigenesis controlled by estrogen-related receptor β

    • Monalisa Parija
    • Surya Prakash
    • Sandip K. Mishra

    Original Article 29 February 2024 Pages: 440 - 455

    

13. The influence of a previous implant-based breast reconstruction on postoperative sensation of the deep inferior epigastric artery perforator flap

    • Joep A. F. van Rooij
    • Ennie Bijkerk
    • Stefania M. H. Tuinder

    Original Article Open access 06 April 2024 Pages: 456 - 466

    

14. Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile

    • Danbee Kang
    • Seri Park
    • Yeon Hee Park

    Original Article 12 March 2024 Pages: 467 - 475

15. Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer

    • Kazutaka Narui
    • Toshihiko Satake
    • Itaru Endo

    Original Article 21 March 2024 Pages: 476 - 484

    

16. Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer

    • Kim Vo
    • Colton Ladbury
    • Arya Amini

    Original Article Open access 20 March 2024 Pages: 485 - 495

    

17. Prognosis of primary breast salivary gland-type carcinoma: a propensity score-matching analysis with invasive carcinoma of no special type based on the SEER database for years 2010–2020

    • Ewe Seng Ch’ng

    Original Article 28 March 2024 Pages: 496 - 506

    

18. Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy

    • Hiroko Nogi
    • Akiko Ogiya
    • The Collaborative Study Group of Scientific Research of The Japanese Breast Cancer Society

    Original Article Open access 04 April 2024 Pages: 507 - 518

    

19. Associations of pre-diagnosis physical activity with treatment tolerance and treatment efficacy in breast cancer patients with neoadjuvant chemotherapy

    • Dan Lin
    • Kathleen M. Sturgeon
    • Cheryl L. Thompson

    Original Article 02 April 2024 Pages: 519 - 528

20. A novel approach correlating pathologic complete response with digital pathology and radiomics in triple-negative breast cancer

    • Sean M. Hacking
    • Gabrielle Windsor
    • Yihong Wang

    Rapid Communication 13 February 2024 Pages: 529 - 535

    

21. Reply to comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al.

    • Reiko Fukui
    • Takahiro Watanabe
    • Yasuo Miyoshi

    Letter to the Editor 04 March 2024 Pages: 536 - 538